Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? A considerable percentage of the population has received both primary and booster vaccinations, which could potentially provide protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infections and related symptoms. WHAT IS ADD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Di, He, Guanhao, Li, Huanlong, Tan, Haomin, Ji, Xiaohui, Lin, Ziqiang, Hu, Jianxiong, Liu, Tao, Xiao, Jianpeng, Liang, Xiaofeng, Ma, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2023
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184382/
https://www.ncbi.nlm.nih.gov/pubmed/37197449
http://dx.doi.org/10.46234/ccdcw2023.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184382/
https://www.ncbi.nlm.nih.gov/pubmed/37197449
http://dx.doi.org/10.46234/ccdcw2023.070

Ejemplares similares